1. Optovue

    0 Comments Leave a Comment

    1-15 of 756 1 2 3 4 ... 49 50 51 »
    1. Mentioned In 756 Articles

    2. Agreement in Measures of Macular Perfusion between Optical Coherence Tomography Angiography Machines

      Agreement in Measures of Macular Perfusion between Optical Coherence Tomography Angiography Machines
      We evaluated the agreements in foveal avascular zone (FAZ) area and vessel density (VD) parameters (within the superficial capillary plexus region), between two widely used optical coherence tomography angiography machines. Participants who attended the Singapore Malay Eye Study III between 29th March and 6th August 2018, were enrolled in this study. Participants underwent fovea-centered 66-mm macular cube scan, using both AngioVue and Cirrus HDOCT machines. Scans were analyzed automatically using ...
      Read Full Article
    3. Study of retinal nerve fiber layer analysis using optical coherence tomography in different demyelinating diseases and its correlation with the severity of visual impairment

      Study of retinal nerve fiber layer analysis using optical coherence tomography in different demyelinating diseases and its correlation with the severity of visual impairment
      ...nation, and dilated fundus examination (DFE). RNFL thickness was measured using spectral domain OCT (SD-OCT) (Optovue RTVue-V6.11 A Fourier). Intergroup analysis of RNFL thickness was done using a Chi-square test (P < 0....
      Read Full Article
      Mentions: Optovue
    4. RTVue XR AngioVue Optical Coherence Tomography Angiography Software Upgrade Impacts on Retinal Thickness and Vessel Density Measurements

      RTVue XR AngioVue Optical Coherence Tomography Angiography Software Upgrade Impacts on Retinal Thickness and Vessel Density Measurements
      ...inal vessel density (VD) measurements derived from optical coherence tomography angiography (OCTA). Methods : Optovue OCTA images (3 3 mm) from 126 individuals (105 healthy eyes and 72 eyes with retinal disease) were ac...
      Read Full Article
    5. Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices

      Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices
      The aim of this paper was to distinguish the appearance of cysts and non-perfusion areas (NPAs) in diabetic macular edema (DME) using two different Optical Coherence Tomography Angiography (OCTA) devices. In this study, patients underwent OCTA using the AngioVue XR Avanti Spectral Domain (SD) OCTA and the PLEX Elite 9000 Swept-Source (SS) OCTA. Foveal and extrafoveal regions of interest (ROI), defined as any area with an altered flow signal comparing ...
      Read Full Article
    6. 1-15 of 756 1 2 3 4 ... 49 50 51 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Optovue

    Optovue

    Optovue, Inc., a privately-held medical device company founded in 2003 and based in Fremont, Calif., is dedicated to the development and commercialization of high-speed optical coherence technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. For more information, visit www.optovue.com.

  3. Quotes about Optovue

    1. Our customers around the world provided a 19% revenue increase for 2009 over 2008...We have continuing strong support by representatives and distributor's world-wide, and all regions including the US are up significantly from 2008. The first fiscal quarter of 2010 demonstrated still another significant increase over 2009 numbers. The trend is clearly demonstrating that the clinical package offered by Optovue products is still highly desirable when faced with a number of product options.
      Gordon Wong in Optovue Announces 19% 2009 Revenue Increase Over 2008
    2. Gaining market share in the home country where Optovue manufactures is always satisfying...“Gaining market share in the home country where Optovue manufactures is always satisfying...The mission in 2012 is to continue our market growth world-wide utilizing our new TCP (Total Cornea Power) and V TRAC (Eye Tracking) options; as well as expand our iWellness programs.
      In Optovue Announces US sales orders for advanced OCT up 32% over previous year
    3. Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry.
      In Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle